TETTAMANTI, SARAH
 Distribuzione geografica
Continente #
NA - Nord America 1.548
EU - Europa 951
AS - Asia 260
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.767
Nazione #
US - Stati Uniti d'America 1.535
IT - Italia 370
IE - Irlanda 194
CN - Cina 138
DE - Germania 138
SE - Svezia 107
HK - Hong Kong 50
GB - Regno Unito 39
IN - India 31
FI - Finlandia 15
UA - Ucraina 15
BE - Belgio 13
CA - Canada 13
DK - Danimarca 12
VN - Vietnam 11
JP - Giappone 10
FR - Francia 9
AT - Austria 6
RO - Romania 6
RU - Federazione Russa 6
TR - Turchia 6
NL - Olanda 5
CH - Svizzera 4
NO - Norvegia 4
PK - Pakistan 4
TW - Taiwan 4
ES - Italia 3
RS - Serbia 3
SG - Singapore 3
BR - Brasile 2
IL - Israele 2
PE - Perù 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AU - Australia 1
BO - Bolivia 1
CO - Colombia 1
MY - Malesia 1
PL - Polonia 1
Totale 2.767
Città #
Ann Arbor 429
Chandler 196
Dublin 188
Milan 119
Fairfield 114
Frankfurt am Main 105
Ashburn 92
Wilmington 78
Seattle 74
Woodbridge 62
New York 58
Houston 51
Hong Kong 48
Cambridge 47
Princeton 39
Shanghai 38
Bergamo 34
Dearborn 28
Lissone 22
Nanjing 21
Altamura 17
Lawrence 14
Brussels 13
Carrboro 11
Jacksonville 11
Monza 11
Carate Brianza 10
Helsinki 10
Hyderabad 10
Andover 8
Fremont 8
Rome 8
Tokyo 8
Hangzhou 7
London 7
Beijing 6
Missaglia 6
Chicago 5
Contursi 5
Edmonton 5
Jinan 5
Naples 5
Pioltello 5
Pune 5
Turin 5
Vienna 5
Bologna 4
Caronno Pertusella 4
Ottawa 4
San Diego 4
Zhengzhou 4
Amstelveen 3
Bergen 3
Boardman 3
Brescia 3
Cerreto Guidi 3
Delhi 3
Durham 3
Genoa 3
Guangzhou 3
Kocaeli 3
Legnano 3
Manchester 3
Muggiò 3
Mumbai 3
Nanchang 3
New Taipei 3
Pavia 3
Perugia 3
Singapore 3
Torino 3
Toronto 3
Washington 3
Borca 2
Boston 2
Carate 2
Catania 2
Changsha 2
Charlottesville 2
Chengdu 2
Desio 2
Dong Ket 2
Florence 2
Forlì 2
Genova 2
Grafing 2
Hefei 2
Jiaxing 2
Kiev 2
Kunming 2
Lahore 2
Lappeenranta 2
Lima 2
Madrid 2
Mathi 2
Metairie 2
Nagold 2
Norwalk 2
Padova 2
Paris 2
Totale 2.193
Nome #
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies 281
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 246
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 226
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 226
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 222
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia 212
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going? 185
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia 121
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions 119
The management of haemoglobin interference for the MALDI-MSI analysis of in-vivo thyroid biopsies 108
CXCR4-MODIFIED CD33.CAR-CIK WITH ENHANCED BONE MARROW HOMING IN ACUTE MYELOID LEUKEMIA 107
Combining the Expression of CD33.CAR and CXCR4 to Increase CAR-CIK Cell Homing to Bone Marrow Niche and Leukemic Stem Cell Eradication in Acute Myeloid Leukemia 96
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the Acute Myeloid Leukemia burden 92
Catch me if you can: how AML and its niche escape immunotherapy 87
Optimization of therapeutic T cell expansion in G-Rex device and applicability to large-scale production for clinical use 86
Cellule CD33.CAR-CIK ingegnerizzate per co-esprimere il recettore CXCR4 al fine di aumentare la capacità di migrazione all’interno della nicchia midollare nella leucemia mieloide acuta 77
Generation of CIK cells co-expressing CXCR4 and CD33.CAR with improved homing and antitumor activity for AML 67
CXCR4-modified CD33.CAR-CIK with enhanced bone marrow homing in Acute Myeloid Leukemia 62
Combining the expression of CD33.CAR and CXCR4 to augment CAR-CIKs homing to bone marrow niche and leukemic stem cell eradication in acute myeloid leukemia 61
Overexpression of CXCR4 receptor on CD33.CAR-CIK cells enhances the control of the Acute Myeloid Leukemia burden 49
Overexpression of CXCR4 Enhances the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia 41
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML 35
Engineering tandem CD33xCD146 CAR CIK (cytokine-induced killer) cells to target the acute myeloid leukemia niche 33
Improving Bone Marrow Homing and Persistence of CD33.CAR-CIK Cells By Overexpression of a Gain-of-Function Variant of CXCR4 to Increase Efficacy in Acute Myeloid Leukemia 30
Ingegnerizzazione di cellule CD33.CAR-CIK con una variante gain-of-function del recettore CXCR4 per aumentarne migrazione e persistenza nella nicchia midollare 27
CARs are sharpening their weapons 19
Acute Myeloid Leukemia (AML) immunotherapy: development of TIM3-CD33 targeted Dual CAR CIK cells for eradication of LSCs in the bone marrow niche 13
Totale 2.928
Categoria #
all - tutte 9.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.358


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201957 0 0 0 0 0 0 0 0 0 0 27 30
2019/2020309 31 21 22 28 30 44 48 20 20 11 12 22
2020/2021627 20 72 136 55 51 62 39 46 33 43 29 41
2021/2022340 23 33 22 18 20 18 11 15 24 32 24 100
2022/2023737 102 174 70 66 17 97 19 53 51 4 60 24
2023/2024679 32 30 45 61 72 181 123 47 61 19 8 0
Totale 2.928